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Neonatal sepsis (NS) is a major cause of morbidity worldwide and one of the three primary causes of 2.7 million deaths every year [1]. Over 600,000 of these deaths are attributed 
to infections alone and 99% of these deaths take place in developing 
countries [2]. South Asia accounts for 3.5 million cases per year [3]. 
Although population-based figures are unavailable, the bulk of these 
sepsis-related neonatal deaths are considered to be taking place in 
rural India, where more than 60% of the Indian population lives. In 
the context of the worldwide threat of antimicrobial resistance, India’s 
condition is considered starker than any other place [4], and neonatal 
infections form an important piece in the equation. Although there is 
no consensus on the exact modalities, various home-based regimens 
of empiric injectable and oral antibiotics are promoted in many 
developing country settings, including India [5]. The present study 
was done to determine the prevalence of NS in the newborn intensive 
care unit (NICU) and to isolate the common organisms involved.
MATERIALS AND METHODS
This is a retrospective study done in the tertiary care hospital 
of Central India after obtaining approval from the Institutional 
Ethical Clearance Committee. All newborns of age <28 days with 
informed consent from parents/guardians were included in the 
present study. Infants, aged >28 days, orphans, and infants for 
whom consent could not be taken from guardians, were excluded 
from the study. A purposive sampling method was adopted to 
collect the required data, as shown in Fig. 1.
We analyzed the data of the culture of NS cases from February 
2018 to February 2019. A semi-structured questionnaire-based 
detailed pro forma was used to collect the data, retrospectively 
including details of antenatal, natal, and postnatal periods. All 
the newborns included in the present study were assessed for 
the gestation age clinically by New Ballard Score. Neonates 
with high index of suspicion for sepsis and showing signs and 
symptoms were noted. Relevant investigations (sepsis screening, 
blood culture, and sensitivity) sent were analyzed accordingly.
Blood for bacterial culture was collected aseptically and 
2 ml of blood was added to each of the two bottles containing 
20 ml of Tryptone Soya Broth (HiMedia Labs., Mumbai, India). 
The bottles were incubated aerobically at 37°C for 7 days and 
subcultured on sheep blood agar and MacConkey agar overnight, 
for 48 h or for 7 days or for an in-between period when visible 
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turbidity appeared. In positive cases, Gram-positive isolates 
were identified at the species level by conventional biochemical 
and serological tests [6]. In the cases, where coagulase-negative 
Staphylococcus aureus (CONS) was isolated in the first 3 days of 
life, a repeat blood culture was performed to confirm the infection.
Proven sepsis was defined as the presence of clinical features 
of sepsis along with the isolation of an organism in the blood 
culture. All organisms were classified based on the time-point 
at which the blood was collected for culture as those causing 
early-onset sepsis (EOS – ≤ 72 h of life) and those causing late-
onset sepsis (LOS – >72 h of life). Thorough clinical examination 
was done and the treatment was provided as per standard 
protocols. The outcome of cases was also noted. The definitions 
and terminologies described in the study were based on standard 
sources approved and adapted by the National Neonatology 
Forum of India.
RESULTS
Of 223 newborns enrolled, 91 were inborn and remaining 132 
were outborn with gender ratio being 2.37:1. Of the 132 outborn 
deliveries, 25 delivered occurred at primary health centers, 48 
at community health centers, 45 at DHs, 6 at home, and 3 were 
delivered on the way to hospital. Among enrolled neonates, 150 
were term, 49 preterm, 20 late preterm and 4 post-term with 39 
neonates being small for date, 170 appropriate for date, and 4 
were large for date.
The major morbidities noted in these neonates were 
sepsis (53.8%) and respiratory distress (32.7%), followed by 
hyperbilirubinemia (23.3%), birth asphyxia (14.3%), seizure 
(8.9%) hematological problems (5.3%), congenital malformations 
(4.48%), metabolic problems (4%), and miscellaneous (0.8%).
Sepsis (32.23) and prematurity (18.83%) were the two most 
common causes of mortality, followed by meconium aspiration 
syndrome (13.9%), hyaline membrane disease (13.4%), birth 
asphyxia (9.8%), sudden infant death syndrome (6.89%), 
pneumothorax (5.3%), congenital malformations (4.48%), and 
hydrops fetalis (0.89%).
A total of 120 cultures were found to be positive out of 
223 cases (53.8.0%). The most common organism isolated was 
S. aureus (39.3%) followed by Klebsiella pneumoniae (34%) 
and Escherichia coli (15%). Other organisms were much less 
in number which included pathogenic streptococci (3.4%), 
CONS (3.1%), Pseudomonas (1.2%), Acinetobacter (1%), and 
Enterobacter (0. 5%) species. Candida albicans also isolated in 
1% of cases.
DISCUSSION
Empirical antibiotics should be started immediately after obtaining 
cultures as NS is an important cause for mortality [7]. Although 
blood culture is the gold standard for the diagnosis of NS, the 
use of intrapartum antibiotics and empirical antibiotics before 
collecting blood for culture decreases the yield of culture [8,9]. 
For choosing the appropriate empirical therapy, one should be 
aware of the common organisms causing EOS and LOS so that 
the antibiotic resistance and emergence of multidrug resistance 
(MDR) organisms can be reduced.
The blood culture positivity in neonates with clinical suspicion 
of sepsis was 53.8% during the given study period which was 
similar to the study done by Mohsen et al. [10]. It was only 
18% in a study done by Bhat et al. [11] and 26.57% in a study 
conducted by Roy et al. [12]. In a study done by Hamer et al., 
the blood culture results of NS from South Asian region showed 
Klebsiella in 23%, E. coli in 12%, S. aureus in 9.8%, and Group B 
Streptococcus in 0.8% of cases with NS during the first 28 days 
of life [13].
The results from the present study showed the predominance 
of Gram-positive organisms over Gram-negative organisms, 
which are in accordance to the results obtained by Rashmi and 
Praveen [14]. Two tertiary care centers in India contributed data 
on 34 bacterial isolates. In this report, S. aureus predominated, 
followed by Acinetobacter spp., Enterobacter spp., E. coli, and 
Klebsiella [15]. The results were in accordance to the present 
study. The study conducted by Apparao et al. showed S. aureus 
(40.3%) as the most common bacterial isolate. The other Gram-
positive organisms to be isolated were streptococcal species and 
CONS [16]. National Neonatal Perinatal Database 2002–2003 
data showed that the most common organisms causing NS were 
K. pneumoniae followed by S. aureus [17].
In developing countries, rates of bloodstream infections 
have been reported to be 1.7–33/1000 live births, with rates 
in Asia clustering around 15/1000 live births [18]. The rate of 
admission of EOS and LOS and the prevalence of organisms 
and their sensitivity patterns were similar [19]. This may be 
due to the fact that the vertical transmission and the horizontal 
spread of infection play an important role in EOS in hospitalized 
neonates [20,21]. The antibiotics used should be specific based on 
culture and sensitivity.
Regular antenatal care, special care of at-risk neonates such 
as preterm and low birth weight babies, exclusive breastfeeding, 
proper hand washing, early diagnosis, and appropriate 
management of infection all remain as major pillars in controlling 
sepsis in neonates. Therefore, the knowledge of prevailing strains 
and the antibiotic sensitivity patterns in the region is mandatory 
Total neonates admitted 
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Figure 1: Sampling method
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for each center due to temporal changes in the causative organisms 
and their antibiotic susceptibility. Periodic evaluations not only 
reveal the recent trend of increasing resistance to commonly used 
antibiotic but also help in implementation of a rational empirical 
therapy.
There were few limitations of this study. Statistical analysis 
could not be carried out. Although the bacteriological profile 
was studied, we did not analyze the specific antibiotics used. The 
growth pattern of the organisms associated with EOS and LOS 
was also not studied.
CONCLUSION
Every NICU should develop their antibiogram to have appropriate 
antibiotic stewardship and decrease the incidence of MDR. 
Therefore, empirical regimen should be modified accordingly.
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